Skip to main content
. 2021 Apr 20;12:662089. doi: 10.3389/fneur.2021.662089

Table 4.

Differences in cerebral physiology in relation to hyperosmolar therapy without intracranial hypertension.

Physiologic variable Prior to treatment [mean (SD)] After treatment [mean (SD)] p-value
ICP, median (mmHg) 11.06 (4.96) 12.81 (10.49) <0.0001
ABP, median (mmHg) 77.78 (11.25) 78.57 (11.07) <0.0001
HR, median (bpm) 99.87 (29.35) 97.22 (31.19) <0.0001
PRx, median 0.09 (0.41) 0.10 (0.40) <0.0001
PAx, median −0.22 (0.37) −0.24 (0.36) 0.0005
wPRx, median 0.04 (0.35) 0.03 (0.36) <0.0001
RAC, median −0.35 (0.42) −0.38 (0.40) <0.0001
RAP, median 0.46 (0.39) 0.48 (0.38) <0.0001
AMP, median 1.21 (1.17) 1.26 (1.15) <0.0001
HRsd, median 3.11 (1.82) 3.38 (2.39) <0.0001
HRrmssd, median 18.75 (18.43) 20.89 (19.46) <0.0001
LHF Ratio, median 1.59 (1.56) 2.95 (10.81) <0.0001

Analysis performed using one-way repeated-measures analysis of variance. Bold variables are representative of statistical significance. ICP, intracranial pressure; ABP, arterial blood pressure; HR, heart rate; bpm, beats per minute; mmHg, millimeters of mercury; PRx, pressure reactivity index; PAx, pulse amplitude index; wPRx, wavelet-pressure reactivity; RAC, correlation coefficient between intracranial pressure pulse amplitude and cerebral perfusion pressure; RAP, correlation coefficient between intracranial pressure pulse amplitude and intracranial pressure; AMP, intracranial pressure pulse amplitude; HRsd, standard deviation of heart rate; HRrmssd, root mean square of successive differences of heart rate; LHF, low frequency-high frequency ratio.